2020
DOI: 10.1038/s41385-019-0192-y
|View full text |Cite
|
Sign up to set email alerts
|

The antibody/microbiota interface in health and disease

Abstract: The human intestine is densely colonized with commensal microbes that stimulate the immune system. While secretory Immunoglobulin (Ig) A is known to play a crucial role in gut microbiota compartmentalization, secretory IgM, and systemic IgG have recently been highlighted in host-microbiota interactions as well. In this review, we discuss important aspects of secretory IgA biology, but rather than focusing on mechanistic aspects of IgA impact on microbiota, we stress the current knowledge of systemic antibody r… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
37
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
9
1

Relationship

1
9

Authors

Journals

citations
Cited by 49 publications
(37 citation statements)
references
References 110 publications
(177 reference statements)
0
37
0
Order By: Relevance
“…5,[7][8][9][10][11][12][13][14][15][16] Considering the enormous numbers and highly variable species diversity along with the large number of potential antigenic determinants on bacterial structures, it is probable that all three mechanisms participate in the protective activity of secretory IgA (SIgA). [2][3][4][5]8,17,18 We reported that the binding of gram-negative bacteria to the glycan receptors on epithelial cells is inhibited by IgA-associated glycans as confirmed and extended to other species of both gram-positive and gramnegative bacteria. 10,17,[19][20][21][22] In addition to the heavy (H) α chains of IgA, secretory component (SC), the extracellular part of the polymeric Ig receptor (pIgR), is heavily glycosylated and acts as a highly effective inhibitor of bacteria adherence to epithelial cells 7,10,13,14,19,20,23,24 thus enforcing the protective functions of SIgA.…”
Section: Introductionmentioning
confidence: 69%
“…5,[7][8][9][10][11][12][13][14][15][16] Considering the enormous numbers and highly variable species diversity along with the large number of potential antigenic determinants on bacterial structures, it is probable that all three mechanisms participate in the protective activity of secretory IgA (SIgA). [2][3][4][5]8,17,18 We reported that the binding of gram-negative bacteria to the glycan receptors on epithelial cells is inhibited by IgA-associated glycans as confirmed and extended to other species of both gram-positive and gramnegative bacteria. 10,17,[19][20][21][22] In addition to the heavy (H) α chains of IgA, secretory component (SC), the extracellular part of the polymeric Ig receptor (pIgR), is heavily glycosylated and acts as a highly effective inhibitor of bacteria adherence to epithelial cells 7,10,13,14,19,20,23,24 thus enforcing the protective functions of SIgA.…”
Section: Introductionmentioning
confidence: 69%
“…Interestingly, ILFs from aged mice produce lower amounts of chemokines yet produce more IgA than their younger counter parts. ILFs and their precursors are present in GF mice 50 , but microbial colonization promotes the maturation of these TLTs 40 , and intestinal microbiota are frequently the antigenic target of IgA produced therein 51 . These studies establish that TLTs do not absolutely require a live microbiota, implying that they could target non-microbial antigens as well.…”
Section: Discussionmentioning
confidence: 99%
“…As we showed here, E2 can also modulate the effect of SCFAs, the major metabolites of gut commensal bacteria. The gastrointestinal microbiome profoundly impacts on various immune responses, including B cell maturation, activation and IgA antibody responses (115,116). In the gut, which contains high concentration of butyrate and propionate, IgA is produced extensively.…”
Section: Discussionmentioning
confidence: 99%